Literature DB >> 18556972

Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings.

Selim Kurtoglu1, Nihal Hatipoglu, Mehmet Keskin, Mustafa Kendirci, Mustafa Akcakus.   

Abstract

Thiamine responsive megaloblastic anemia syndrome (TRMA), an autosomal recessive disorder caused by the deficiency of thiamine transporter protein, is the association of diabetes mellitus, anemia and deafness. Pharmacological dose thiamine normalizes hematological abnormalities and their effects on the course of diabetes mellitus. We report on 8 years follow up of two siblings with TRMA. They presented in the prepubertal period with diabetic ketoacidosis due to lack of thiamine supplementation for 2 months. Their insulin requirements fell rapidly and disappeared with thiamine therapy. Hematological parameters normalized within 30 days. The diabetic picture is responsive to thiamine treatment in patients with TRMA. Insulin dependent diabetes may occur throughout the pubertal period. If thiamine supplementation is not sufficient, ketoacidosis may develop in patients during the prepubertal period.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556972     DOI: 10.1515/jpem.2008.21.4.393

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  5 in total

1.  Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.

Authors:  Anke K Bergmann; Inderneel Sahai; Jill F Falcone; Judy Fleming; Adam Bagg; Caterina Borgna-Pignati; Robin Casey; Luca Fabris; Elizabeth Hexner; Lulu Mathews; Maria Leticia Ribeiro; Klaas J Wierenga; Ellis J Neufeld
Journal:  J Pediatr       Date:  2009-07-29       Impact factor: 4.406

2.  Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome?

Authors:  Leyla Akın; Selim Kurtoğlu; Mustafa Kendirci; Mustafa Ali Akın; Musa Karakükçü
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-02-23

3.  The impact of thiamine treatment in the diabetes mellitus.

Authors:  Khanh Vinh Quoc Luong; Lan Thi Hoang Nguyen
Journal:  J Clin Med Res       Date:  2012-05-15

4.  Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.

Authors:  Nosrat Ghaemi; Martha Ghahraman; Mohammad Reza Abbaszadegan; Alireza Baradaran-Heravi; Rahim Vakili
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-09-10

5.  TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.

Authors:  Xin Li; Qing Cheng; Yu Ding; Qun Li; Ruen Yao; Jian Wang; Xiumin Wang
Journal:  BMC Pediatr       Date:  2019-07-11       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.